PeptideDB

VUT-MK142 1313491-22-3

VUT-MK142 1313491-22-3

CAS No.: 1313491-22-3

VUT-MK142 is a novel, potent and cardiomyogenic agent promoting the differentiation of pre-cardiac mesoderm into cardiom
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

VUT-MK142 is a novel, potent and cardiomyogenic agent promoting the differentiation of pre-cardiac mesoderm into cardiomyocytes, which may be useful to differentiate stem cells into cardiomyocytes for cardiac repair.



Physicochemical Properties


Molecular Formula C17H22N4O
Molecular Weight 298.382783412933
Exact Mass 298.179
CAS # 1313491-22-3
PubChem CID 53261094
Appearance White to off-white solid powder
Density 1.2±0.1 g/cm3
Boiling Point 499.9±40.0 °C at 760 mmHg
Flash Point 256.1±27.3 °C
Vapour Pressure 0.0±1.3 mmHg at 25°C
Index of Refraction 1.638
LogP 5.35
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 5
Heavy Atom Count 22
Complexity 314
Defined Atom Stereocenter Count 0
SMILES

O(C)C1C=CC(=CC=1)NC1=CC(=NC=N1)NC1CCCCC1

HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro The cardiomyogenic effects of VUT-MK142 on various cell types are promising. It was observed that VUT-MK142 significantly affected P19 and C2C12 cells. Treatment with VUT-MK142 led to a stronger upregulation of ANF expression than CgC [1]. After 7 days of treatment, VUT-MK142 (1 μM) significantly (p < 0.05) increased the luciferase signal in P19 cells by 3.1 ± 0.3 luciferase (n = 5) times [1].
References [1]. Moumita Koley, et al. VUT-MK142 : a new cardiomyogenic small molecule promoting the differentiation of pre-cardiac mesoderm into cardiomyocytes. Medchemcomm. 2013 Aug 1;4(8):1189-1195.

Solubility Data


Solubility (In Vitro) DMSO : ~25 mg/mL (~83.79 mM)
Solubility (In Vivo) Solubility in Formulation 1: 2.5 mg/mL (8.38 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (8.38 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.3514 mL 16.7572 mL 33.5143 mL
5 mM 0.6703 mL 3.3514 mL 6.7029 mL
10 mM 0.3351 mL 1.6757 mL 3.3514 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.